VTN and Alzheimer disease: Expression studies have reported elevated expression of the complement receptors C3aR1 and C5aR1 and complement proteins C4A, C4B and CFHR1 in AD compared with age-matched controls, while C1q binding protein (C1qBP) expression was decreased [54].